This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Exploring Analyst Estimates for European Wax Center (EWCZ) Q1 Earnings, Beyond Revenue and EPS
by Zacks Equity Research
Looking beyond Wall Street's top -and-bottom-line estimate forecasts for European Wax Center (EWCZ), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended March 2025.
Coty (COTY) Lags Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Coty (COTY) delivered earnings and revenue surprises of -80% and 0.43%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Estee Lauder (EL) Q3 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Estee Lauder (EL) delivered earnings and revenue surprises of 124.14% and 1.22%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Helen of Troy (HELE) Misses Q4 Earnings Estimates
by Zacks Equity Research
Helen of Troy (HELE) delivered earnings and revenue surprises of -0.43% and 1.17%, respectively, for the quarter ended February 2025. Do the numbers hold clues to what lies ahead for the stock?
4 Cosmetic Stocks to Keep an Eye On Despite Market Challenges
by Ansuiya Mohta
Despite ongoing macroeconomic challenges, companies like EL, COTY, HELE and EWCZ remain well-positioned, backed by digital innovation and strategic brand initiatives.
Estee Lauder (EL) Surges 12.2%: Is This an Indication of Further Gains?
by Zacks Equity Research
Estee Lauder (EL) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
European Wax Center (EWCZ) Upgraded to Strong Buy: What Does It Mean for the Stock?
by Zacks Equity Research
European Wax Center (EWCZ) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Compared to Estimates, European Wax Center (EWCZ) Q4 Earnings: A Look at Key Metrics
by Zacks Equity Research
The headline numbers for European Wax Center (EWCZ) give insight into how the company performed in the quarter ended December 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
European Wax Center, Inc. (EWCZ) Beats Q4 Earnings Estimates
by Zacks Equity Research
European Wax Center (EWCZ) delivered earnings and revenue surprises of 220% and 5.21%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
European Wax Center (EWCZ) Q4 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
by Zacks Equity Research
Besides Wall Street's top -and-bottom-line estimates for European Wax Center (EWCZ), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended December 2024.
EWCZ vs. ELF: Which Stock Is the Better Value Option?
by Zacks Equity Research
EWCZ vs. ELF: Which Stock Is the Better Value Option?
Is Molson Coors (TAP) Outperforming Other Consumer Staples Stocks This Year?
by Zacks Equity Research
Here is how Molson Coors Brewing (TAP) and European Wax Center, Inc. (EWCZ) have performed compared to their sector so far this year.
Nu Skin Enterprises (NUS) Q4 Earnings and Revenues Top Estimates
by Zacks Equity Research
Nu Skin (NUS) delivered earnings and revenue surprises of 72.73% and 1.01%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
EWCZ or ELF: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
EWCZ vs. ELF: Which Stock Is the Better Value Option?
Coty (COTY) Q2 Earnings and Revenues Miss Estimates
by Zacks Equity Research
Coty (COTY) delivered earnings and revenue surprises of -50% and 2.65%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
Estee Lauder (EL) Q2 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Estee Lauder (EL) delivered earnings and revenue surprises of 93.75% and 0.72%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
Will European Wax Center (EWCZ) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
European Wax Center (EWCZ) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
EWCZ vs. ELF: Which Stock Is the Better Value Option?
by Zacks Equity Research
EWCZ vs. ELF: Which Stock Is the Better Value Option?
Zacks Industry Outlook The Estee Lauder, Helen of Troy and European Wax Center
by Zacks Equity Research
The Estee Lauder, Helen of Troy and European Wax Center have been highlighted in this Industry Outlook article.
European Wax Center (EWCZ) Surges 8.0%: Is This an Indication of Further Gains?
by Zacks Equity Research
European Wax Center (EWCZ) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
3 Resilient Cosmetic Stocks to Monitor in a Challenging Market
by Ansuiya Mohta
Despite facing macroeconomic challenges, companies like EL, HELE and EWCZ look well-positioned on digital innovation and strategic initiatives.
Will European Wax Center (EWCZ) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
European Wax Center (EWCZ) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
What Analyst Projections for Key Metrics Reveal About European Wax Center (EWCZ) Q3 Earnings
by Zacks Equity Research
Evaluate the expected performance of European Wax Center (EWCZ) for the quarter ended September 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
Nu Skin Enterprises (NUS) Lags Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Nu Skin (NUS) delivered earnings and revenue surprises of -15% and 3.14%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Zacks Industry Outlook Highlights Coty, Helen of Troy, European Wax Center and Nu Skin
by Zacks Equity Research
Coty, Helen of Troy, European Wax Center and Nu Skin are part of the Zacks Industry Outlook article.